Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT02389127 Completed - Clinical trials for Diabetes Mellitus, Type 2

Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis

Start date: July 2015
Phase: N/A
Study type: Observational

Cirrhosis and advanced liver disease have been associated with an increased risk for hyperglycemia and type 2 diabetes mellitus (T2DM). The diagnostic yield of common tests used to define diabetes and insulin resistance in the general population differs significantly from the one observed in patients with liver disease. Glycosylated hemoglobin A1c (HbA1c), a reliable test to assess chronic glycemia and recommended both for the diagnosis and monitoring of T2DM, is neither accurate nor reliable in patients with cirrhosis. A validation study has not been performed to define its true usefulness in the setting of cirrhosis. The study aims to determine the level of HbA1c that better corresponds to the diagnosis of T2DM - as determined by an oral glucose tolerance test (OGTT) - and to correlate the levels of HbA1c with the average glucose over a 12-week period in patients with cirrhosis and known T2DM, in cirrhotic patients with different degrees of liver impairment as compared to patients with T2DM and no liver disease.

NCT ID: NCT02389114 Completed - Obesity Clinical Trials

Effect of Soy Protein and Polydextrose on Food Intake in Young Chinese Adult Males

Start date: June 2013
Phase: N/A
Study type: Interventional

The primary hypothesis of this study is that the higher concentration of soy protein intake will increase satiety and decrease the energy intake at the subsequent meal. The secondary hypothesis is that the synergistic effect of soy protein and polydextrose will further increase satiety and reduce energy intake at the subsequent meal. The third hypothesis is that the ingestion of protein and polydextrose will differentially impact on satiety-related metabolism, i.e. blood glucose, insulin, urea, plasma amino acids, gut hormones and gastric emptying.

NCT ID: NCT02388815 Completed - Diabetes Mellitus Clinical Trials

Abbott Sensor Based Glucose Monitoring System Paediatric Study

BEAGLE
Start date: March 2015
Phase: N/A
Study type: Interventional

To evaluate the point accuracy of the Abbott Sensor Based Glucose Monitoring System when used at home by children with diabetes.

NCT ID: NCT02388113 Completed - Clinical trials for Diabetes Mellitus, Type 2

Effect of Exercise Frequency on Metabolic Control and Heart Function in Type 2 Diabetes

Start date: October 2014
Phase: N/A
Study type: Interventional

This study will compare two interventions with the same exercise intensities and caloric expenditure but with different exercise frequency, on metabolic control and other risk factors in individuals with type 2 diabetes.

NCT ID: NCT02386579 Completed - Diabetes Mellitus Clinical Trials

Characterization of Local and Systemic Bone Markers in Diabetes Patients With Charcot Osteoarthropathy

Start date: February 2015
Phase:
Study type: Observational

The study is designed to investigate biomarkers related to bone turnover in diabetics with charcot foot. This is done by measuring local blood samples in the feet, and systemically in a vene and an artery. Measurements are done before and after cooling the feet in icewater to lower the bloodflow. Patients will be compared with healthy diabetic controls.

NCT ID: NCT02386540 Completed - Hypertension Clinical Trials

Health Coach Program to Improve Chronic Disease Outcomes Following an Emergency Department Visit

Start date: February 6, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether health coaching initiated in the emergency department (ED) reduces subsequent ED visits, increases primary care visits, and positively impacts health outcomes in patients with diabetes and/or hypertension.

NCT ID: NCT02385890 Completed - Obesity Prevention Clinical Trials

PERFECT Project - Part 1 - Study 3

Start date: October 2016
Phase: N/A
Study type: Interventional

The objectives are to test the acute effects of different bagels containing pulse ingredients on: 1) post-prandial blood glucose, insulin and appetite for two hours, and 2) food intake two hours following consumption of pulse products. The investigators hypothesize that bagels containing pulse ingredients will lead to lower blood glucose, insulin, appetite and food intake responses compared to non-pulse bagels.

NCT ID: NCT02384265 Completed - Diabetes Mellitus Clinical Trials

Financial Incentives and Text Messaging to Improve African American Womens' Glycemic Control

FRIENDS-Text
Start date: June 21, 2012
Phase: N/A
Study type: Interventional

Diabetes is a major public health problem that is associated with substantial health disparities for African American women compared to African American men or white men and women. This project will incorporate a) new technology whose use is high among African Americans (cell phone text message reminders), b) support from social networks, and c) strategies from the emerging field of behavioral economics to encourage and support self care behaviors that lead to improvements in diabetes control. In Stage I of the study, the investigators conducted focus groups with women with diabetes and their family members and friends. The investigators used information from these groups to work with a team of community partners to develop recruitment protocols, prepare study documents (including flyers, Frequently Asked Questions sheets, and informed consent forms), and finalize participant surveys. In the next phase of the study the investigators will evaluate ways that friends and family members can use direct support and text messages to improve control of blood sugar for African American women with type 2 diabetes. A team of three people--the Person With Diabetes (PWD) and 2 friends or family members, also known as the Support Team Members (STMs)--will be assigned at random to one of two groups to compare approaches to improving control of blood sugar. Each team will receive information and resources on improving diabetes control and will be linked by a text messaging program. The intervention team will receive additional text messaging support that may help them improve the PWD's diabetes control.

NCT ID: NCT02384018 Completed - Diabetes Clinical Trials

Mesenchymal Stem Cell and Islet Co-transplantation

Start date: December 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to show safety and tolerability to our mesenchymal stromal cells (MSCs) product which will be autologous in nature, expanded using a non-xenogeneic, human component expansion media (pooled human platelet lysate) and delivered fresh. Subsequently, the investigators intend to test whether infusion of MSCs immediately after islet autograft can reduce onset of diabetes and improve glycemic control after total pancreatectomy and islet autotransplantation.

NCT ID: NCT02383238 Completed - Clinical trials for Diabetes Mellitus Type 2

Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content

Dapa
Start date: March 2014
Phase: Phase 3
Study type: Interventional

Dapagliflozin leads to improved vascular function in the micro- and macrocirculation by action on various cardiovascular risk factors, in particular by effectively controlling hyperglycemia, arterial hypertension and reducing whole sodium content amongst others.